CoChat

IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction

Ren, Jun, Duan, Jinhong, Thomas, D. Paul, Yang, Xiaoping, Sreejayan, Nair, Sowers, James R., Leri, Annarosa, Kajstura, Jan, Gao, Feng, Anversa, Piero · 2008 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Cited by 63

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

IGF-I rescues diabetic heart defects and oxidative stress, although the underlying mechanism of action remains poorly understood. This study was designed to delineate the beneficial effects of IGF-I with a focus on RhoA, Akt, and eNOS coupling. Echocardiography was performed in normal or diabetic Friend Virus-B type (FVB) and IGF-I transgenic mice. Cardiomyocyte contractile properties were evaluated using peak shortening (PS), time-to-90% relengthening (TR 90), and intracellular Ca 2+ rise and decay. Diabetes reduced fraction shortening, PS, and intracellular Ca 2+; it increased chamber size, prolonged TR 90, and intracellular Ca 2+ decay. Levels of RhoA mRNA, active RhoA, and O 2− were elevated, whereas nitric oxide (NO) levels were reduced in diabetes. Diabetes-induced O 2− accumulation was ablated by the NO synthase (NOS) inhibitor nitro-l-arginine methyl ester (l-NAME), indicating endothelial NOS (eNOS) uncoupling, all of which except heart size were negated by IGF-I. The IGF-I-elicited beneficial effects were mimicked by the Rho kinase inhibitor Y27632 and BH 4. Diabetes depressed expression of Kv 1.2 and dihydrofolate reductase (DHFR), increased β-myosin heavy-chain expression, stimulated p38 MAPK, and reduced levels of total Akt and phosphorylated Akt/eNOS, all of which with the exception of myosin heavy chain were attenuated by IGF-I. In addition, Y27632 and the eNOS coupler folate abrogated glucose toxicity-induced PS decline, TR 90 prolongation, while it increased O 2− and decreased NO and Kv 1.2 levels. The DHFR inhibitor methotrexate impaired myocyte function, NO/O 2− balance, and rescued Y27632-induced cardiac protection. These results revealed that IGF-I benefits diabetic hearts via Rho inhibition and antagonism of diabetes-induced decrease in pAkt, eNOS uncoupling, and K+ channel expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpregu.00713.2007

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 63

Metadata

Authors
Ren, J., Duan, J., Thomas, D. P., Yang, X., Sreejayan, N., Sowers, J. R., Leri, A., Kajstura, J., Gao, F., & Anversa, P.
Venue
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Published
2008-03
Volume
294
Issue
3
Pages
R793-R802
ISSN
  • 0363-6119 (ISSN-L)
  • 1522-1490
OpenAlex
W2121815457
Cited by
63
References
1
FWCI
4.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction. https://app.cochat.ai/papers/10.1152/ajpregu.00713.2007
The paper
Ren, J., Duan, J., Thomas, D. P., Yang, X., Sreejayan, N., Sowers, J. R., Leri, A., Kajstura, J., Gao, F., & Anversa, P. (2008). IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. https://doi.org/10.1152/ajpregu.00713.2007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.